In our round table with Tom Keith-Welsh, Senior Director, Digital Health & Innovation at GSK, we explored the evolving opportunities for health tech partnerships in clinical trials and how to effectively engage with pharma. The discussion focused on improving efficiencies, enhancing patient engagement, and advancing clinical innovation.

This post distills key insights, including navigating pharma’s value chain and organizational structure, leveraging digital health solutions to drive efficiencies and patient engagement, and adopting strategic approaches to securing impactful collaborations. By aligning with pharma’s internal priorities, health tech companies can strengthen their positioning and scale solutions globally.

Pharma companies are actively seeking health tech partnerships to bridge care gaps and enhance patient pathways, but navigating these collaborations requires strategic insight. This post breaks down the essential steps discussed during the virtual round table with Jutta Klauer, Strategic Digital Partnerships Director @ MSD Idea Studio Europe—from understanding pharma’s structure to crafting a compelling value proposition—that can help health tech firms secure impactful partnerships and scale their solutions globally.